News | July 29, 2010

Invivo Wins Medical Design Excellence Award for Prostate Solutions

July 29, 2010 - The Medical Design Excellence Award (MDEA) ceremony, held at New York City’s Jacob K. Javits Convention Center, recognized Invivo as its gold winner for their contributions and advances in the design of medical products in early June.

Invivo’s DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions work together to enable physicians to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy.

Invivo’s DynaTRIM is the first commercially available fully magnetic resonance imaging (MRI)-compatible interventional device for Trans-Rectal Interventional MRI of the prostate gland. A removable device, DynaTRIM is designed to affix to an MRI imaging table with an open design that allows for flexibility in coil choice and a cleanable foam pad for extra patient comfort.

Invivo’s DynaCAD for Prostate solution provides physicians with a comprehensive, customizable set of advanced visualization tools for performing real-time analysis of prostate MRI studies.

“The better the sample, the more uniformity in diagnosis and inter-observer variance,” explains David B. Kaminsky, M.D., of Palm Springs Pathology Services. “I have personally witnessed the calm reception of the patient during set-up and biopsy procedure which cultivates the patient’s participation in navigating his illness and reduces anxiety to foster compliance with the technique.”

For more information: www.invivocorp.com

Related Content

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.